Inducing Systemic Immunity and Regressions in Metastatic Melanoma

Clinical trial NCT02350972 · COMPLETED

Trial details

NCT number: NCT02350972
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Melanoma

Start date: 1978-07-01
Primary completion: 2002-05-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.